RETIDIAB®：一个用于改善糖尿病视网膜病变管理的继续医学教育网站的评估。

RETIDIAB®: assessment of a continuing medical education website for the improvement of diabetic retinopathy management.

机构信息

Department of Ophthalmology, hôpital Général, University Hospital, 3, rue du Faubourg-Raines, 21033 Dijon, Dijon, France.

出版信息

Diabetes Metab. 2011 Apr;37(2):118-23. doi: 10.1016/j.diabet.2010.08.009. Epub 2010 Dec 9.

DOI:10.1016/j.diabet.2010.08.009

PMID:21145772

Abstract

AIM

The aim of this study was to evaluate the efficacy of a continuing medical education (CME) website to improve ophthalmological management of diabetic retinopathy (DR).

METHODS

A worldwide website called RETIDIAB® was created in which, to log on for first time, users had to take a preliminary test to evaluate their baseline level of knowledge. This allowed them free access to the entire website at any time with no time obligation. The website comprised a course of theoretical concepts and different types of training, including multiple-choice questionnaires (MCQ) focused on the course content, interpretation of diabetic fundus photographs and case reports. After perusing the entire RETIDIAB® website, users could take a second assessment test. Finally, they were asked to fill in a questionnaire evaluating the entire programme.

RESULTS

A total of 137 users were registered and, of these, 109 took only the preliminary test, while 28 took the second test and evaluated the entire website; of the latter, 75% were residents and 25% were practising physicians, and 15 were male and 13 were female, ranging in age from 26 to 42 (30.2 ± 3) years. Statistically significant progress was seen between the first and second evaluations (37.3 ± 14% correct answers vs 64 ± 10%, respectively), and the average time interval between the first and second evaluations was 40 ± 20 days. In addition, users expressed a high level of overall satisfaction with the site.

CONCLUSION

This pilot study demonstrated the value and effectiveness of RETIDIAB®, a new CME website exclusively devoted to DR management.

摘要

目的

本研究旨在评估继续教育（CME）网站在改善糖尿病视网膜病变（DR）眼科管理方面的疗效。

方法

创建了一个名为 RETIDIAB®的全球性网站，用户首次登录必须参加初步测试，以评估其基础知识水平。这使他们可以随时免费访问整个网站，且没有时间限制。该网站包含理论概念课程和不同类型的培训，包括针对课程内容的多项选择题（MCQ）、糖尿病眼底照片解读和病例报告。在浏览完整个 RETIDIAB®网站后，用户可以参加第二次评估测试。最后，他们被要求填写一份评估整个计划的问卷。

结果

共有 137 名用户注册，其中 109 名仅参加了初步测试，而 28 名参加了第二次测试并评估了整个网站；其中，75%为住院医师，25%为执业医师，15 名男性，13 名女性，年龄在 26 至 42 岁之间（平均年龄为 30.2 ± 3 岁）。第一次和第二次评估之间的正确率呈显著提高（分别为 37.3 ± 14%和 64 ± 10%），且两次评估之间的平均时间间隔为 40 ± 20 天。此外，用户对该网站的整体满意度较高。